The expression of the cell adhesion molecules ICAM-1, ICAM-2, and VCAM-1 and the secretion of the cytokine interleukin 6 have been measured in mouse Sertoli cells cultured in vitro. Cytometric analysis revealed that, in basal conditions, low levels of ICAM-1 and VCAM-1 were present on the surface of the cells, whereas treatment with interleukin 1, tumor necrosis factor a, lipopolysaccharide, or interferon y induced, with different kinetics, increases in their expression. ICAM-2 was not detectable in basal conditions, nor was it inducible. Electron microscopic analysis and binding experiments using 51Cr-labeled lymphocytes demonstrated that increased expression of ICAM-1 and VCAM-1 on the surface of Sertoli cells, induced by inflammatory mediators, determines an augmented adhesion between the two cell types. The same stimuli, with the exception of interferon y, produced a rapid and remarkable increment of interleukin 6 production by Sertoli cells. These results suggest the presence of both direct and paracrine mechanisms of interaction between Sertoli and immune-competent cells, possibly involved in the control of immune reactions in the testis. Such mechanisms are of interest for the understanding of autoimmune pathologies of the testis and, if confirmed in humans, they could be involved in the sexual transmission of human immunodeficiency virus infection.
The testis is an immunologically privileged site of the body (1, 2). Germ cell-linked autoantigens expressed from puberty on are physiologically tolerated in situ, but they elicit strong autoimmune reactions if injected elsewhere in the body (3) . This phenomenon has allowed researchers to use experimental autoimmune orchitis (EAO) as a tool to study the mechanisms of similar spontaneous pathologies (4) .
Sertoli cells, described as "nursing cells" by their discoverer, are both the target for the hormones regulating spermatogenesis and responsible for the maintenance of the specific microenvironment in which postmeiotic development takes place. Immune tolerance in the testis has long been explained on the basis of the fact that Sertoli cells can mechanically segregate all germ cell autoantigens by means of the so called blood-tubular barrier (5) . Additional information, however, revealed that this barrier isolates most, but not all, the autoantigens. Some of them escape the barrier and are available to interstitial immune cells, which nevertheless do not react against them (6) . Recently we have suggested that immune tolerance in the testis may result from the synergistic operation of two mechanisms: segregation of most of the autoantigens
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Even though the mechanisms through which immune tolerance is maintained in the testis seem to be on the way to being clarified, it is still quite obscure how their perturbation leads to autoimmune diseases in the testis.
Sertoli cells could be involved in the negative as well as in the positive regulation of the immune response. In both of these phenomena, accessory cells and lymphocytes interact by means of two basic mechanisms: paracrine messages through cytokines and specific surface interactions (8) . Primary cultures of Sertoli cells maintain their differentiated phenotype, including their ability to respond to follicle-stimulating hormone (FSH) (9) . Cultured Sertoli cells have been demonstrated to secrete interleukin (IL)-1 (10), transferrin, and IL-6 (11) and are active phagocytes (12), but they do not constitutively express major histocompatibility complex (MHC) class II determinants or macrophage-specific markers (13) . Moreover, their production of both transferrin (14) and IL-6 is enhanced by FSH stimulation (11) . Thus, Sertoli cells produce a series of cytokines and factors which act on a variety of cell types and particularly on cells of the immune system. IL-6 is one of the most potent cytokines known to activate T and B lymphocytes (15, 16) . Recently, the possibility has been suggested that deregulation of IL-6 gene expression may be involved in the pathogenesis of autoimmune diseases (17) (18) (19) .
In this article we report that, in cultured mouse Sertoli cells, inflammatory mediators such as IL-la, IL-1,B, tumor necrosis factor a (TNF-a), and lipopolysaccharide (LPS) strongly enhance the surface expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1), known to be specific binding molecules for lymphocytes. Such response is accompanied by a parallel increase in the secretion of biologically active IL-6.
MATERIALS AND METHODS
Sertoli Cell Cultures. Sertoli cells were prepared from CD1 mice as previously described (13) . Briefly, testes from 15-dayold animals were sequentially digested with 0.25% trypsin + DNase at 10 ,ug/ml and then 0.1% collagenase + DNase at 10 jig/ml (Boehringer Mannheim) for 20 min to remove interstitial tissue and peritubular cells. Tubular fragments, mainly composed of Sertoli cells, were cultured at 32°C in 95% air/5%
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§To whom reprint requests should be addressed. Preparation of Splenic Lymphocytes. Spleens from adult CD1 mice were aseptically removed and gently dissociated in culture medium. Red blood cells were eliminated by treatment with ACK-lysing buffer (GIBCO/BRL) and the cell suspension was enriched in T lymphocytes by incubation on a nylon wool column (Polyscience) for 1 hr at 37°C (23) . Cytometric analysis of this population using anti-CD3 mAbs revealed that T lymphocytes accounted for about 50% of the total. Lymphocytes were then resuspended in RPMI 1640 medium supplemented with 10% FCS, 2 mM glutamine, 50 ,uM 2-mercaptoethanol, and gentamicin at 50 ,ug/ml. Splenic Lymphocyte Adhesion Assay. Sertoli cells were plated in Lab-tek tissue culture chamber slides (Nunc) and treated with TNF-a (20 ng/ml) for 20 hr at 32°C, then TNF-a was removed before cells were used for the binding experiments.
Adhesion of lymphocytes to Sertoli cell monolayers was assessed by using 51Cr-labeled lymphocytes in a 51Cr retention assay modified from that described previously (24) . Scanning Electron Microscopy. For scanning electron microscopic observations, Sertoli cells were plated onto glass coverslips, treated with TNF-a at 20 ng/ml for 20 hr, and incubated with splenic lymphocytes at 37°C for 75 min as reported above. After removal of nonadhering lymphocytes, Sertoli cells were fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) for 2 hr. After a thorough wash in cacodylate buffer, the samples were postfixed in 1% aqueous OS04 for 40 min, dehydrated in absolute ethanol, and dried by the critical-point drying method. Specimens were examined under a Hitachi S570 scanning electron microscope. Prepuberal Sertoli cells did not exhibit the presence of ICAM-2 on their surface, whereas small but significant Table 2 . The expression of both ICAM-1 and VCAM-1 is significantly increased, even if to a variable extent, by all the treatments tested. The increase of expression was variable in different experiments, probably due to the complex procedure of cell preparation. For instance, the net (i.e., after subtraction of background) expression of ICAM-1 after the treatment with TNF-a at 20 ng/ml ranged from 19 to 31 times the control value. However, the reproducibility within the same experiment was always good, the relative error in triplicate samples seldom exceeding 5%.
RESULTS

Effects of Inflammatory
Since TNF-a was the most effective factor tested for the induction of adhesion molecules, we have performed doseresponse and time-course experiments with this cytokine. TNF-a induced, within 24 hr, a dose-response increment in the surface expression of the lymphocyte adhesion molecules ICAM-1 and VCAM-1 on Sertoli cell cultures. Maximal stimulation of both ICAM-1 and VCAM-1 expression with TNF-a was obtained at a concentration of about 20 ng/ml ( Fig. 2A) .
Semiquantitative analysis by immunofluorescence showed that not only prepuberal Sertoli cells but also Sertoli cell cultures from young adult mice exhibit a similar response to TNF-a (not shown). In Fig. 2B it can be seen that Sertoli cells respond to the stimulus as early as after 4 hr of treatment, reaching the maximal concentration of ICAM-1 and VCAM-1 on their surface between 16 and 24 hr of treatment.
Role of ICAM-1 and VCAM-1 in Lymphocyte Adhesion to
Cytokine-Stimulated Sertoli Cells. Binding experiments have been employed to detect the actual ability of lymphocytes to specifically adhere to Sertoli cells untreated or treated with TNF-a. Fig. 3 shows that stimulation of Sertoli cells with TNF-a increased their ability to bind activated lymphocytes. (26) .
About 50% of the lymphocytes added were T lymphocytes (see Materials and Methods). Immunofluorescence search for CD3-positive cells among those adhering to Sertoli cell monolayers confirmed this ratio. To obtain a quantitative evaluation of this effect, we performed similar experiments, using 51Cr-labeled lymphocytes, and found that treatment with TNF-a doubled the binding of lymphocytes to Sertoli cell monolayers. Such response is related to the augmented expression of these adhesion molecules, since anti-ICAM-1 and anti-VCAM-1 neutralizing antibodies strongly inhibited the binding of lymphocytes to stimulated Sertoli cells (Fig. 4) .
Production of Biologically Active IL-6 by Sertoli Cells and Its Modulation by Cytokines. We have also measured the production of biologically active IL-6 by Sertoli cells. TNF-a increased the basal production of IL-6 in a dose-dependent manner (Fig. SA) . A similar effect was obtained when IL-la, IL-1f3, or LPS was used (not shown). Treatment with IFN-,y induced a significant decrease of the basal secretion of IL-6 (Fig. SB) . IL-6 activity was evaluated as a function of the growth of the IL-6-dependent cell line B9, and the specificity was assessed with anti-IL-6 neutralizing antibodies. Timecourse experiments demonstrated that, during the first 24 hr of treatment with TNF-a at 20 ng/ml, increased production of IL-6 parallels the augmented expression of ICAM-1 and VCAM-1 (Figs. 6 and 2B ).
DISCUSSION
We demonstrated that mouse Sertoli cells cultured in vitro respond to treatments with inflammatory mediators, such as TNF-a, IL-la, IL-1p, and LPS, by increasing the expression of ICAM-1 and of VCAM-1 on their surface. This pattern of cytokine-upregulated expression is in agreement with previous -13p
.i studies using other cell types (27) . The extent of the response to TNF-a in the Sertoli cell cultures is in the same range of that obtained with TNF-a or with other factors in the most responsive systems, including endothelial cells (28, 29) . Such responses are associated with an augmented specific adhesion of lymphocytes to the surface of Sertoli cells and to a contemporary enhanced secretion of IL-6. The adhesion mechanisms involve both ICAM-1 and VCAM-1, since neutralizing mAbs to one or the other adhesion molecule strongly inhibited the increase of the binding.
Our data show that IFN-,y enhances the expression of ICAM-1 and VCAM-1 but, differently from the other factors tested, inhibits rather than stimulates the secretion of biologically active IL-6 by Sertoli cells. A reduced production of IL-6 after IFN-,y treatment has been observed in rat granulosa cells also (30) . These results suggest that the regulation of the expression of adhesion molecules and of the production of IL-6 could follow, in our system, separate pathways.
It has been proposed that IL-6 secretion by rat Sertoli cells might be relevant in the paracrine regulation of spermatogenesis (11) . Gene targeting has been recently used to produce mice deficient in ICAM-1 (31) or IL-6 (32) . These animals exhibit, respectively, prominent abnormalities in inflammatory responses and impaired immune and acute-phase responses. These data confirm, therefore, the key role of adhesion molecules and IL-6 in both lymphocyte inflammatory response and lymphocyte activation. However, mice deficient for IL-6 are fertile, indicating that IL-6 does not play any important role in the regulation of testicular functions.
Adhesion and migration of leukocytes through the capillary wall, during the inflammatory process, implies a series of (34, 35) , more restricted for VCAM-1 (36, 37) . These molecules are considered responsible for adhesion to endothelial cells and migration of leukocytes from the blood stream to inflamed tissues (33) . An increasing body of evidence suggests that nonendothelial cells of the various tissues can be involved in the local accumulation of leukocytes and in the regulation of the immune response. It has been recently shown that inflammatory stimuli can induce, for instance, human myoblasts or keratinocytes to trigger or enhance immune reactions through the expression of specific surface molecules and the secretion of cytokines which activate T lymphocytes (38, 39) .
The Sertoli cell is involved in the hormonal regulation of spermatogenesis, but it is also responsible for a series of other functions, including the formation and the maintenance of the blood-tubular barrier, the control of the tubular microenvironment, the regulation of spermiation, and the removal of abnormal germ cells (9) . In addition to that, Sertoli cells are implicated in the immune tolerance of testicular autoantigens, not only by segregating them within the blood-tubular barrier but also by secreting an immunosuppressive factor(s) (7) . Previous studies, attempting to characterize Sertoli cells as antigen-presenting cells, have shown the presence on their surface of class I MHC antigens, but failed to demonstrate the expression of class II determinants specific for accessory cells such as dendritic cells (13) . 
